DANIYEL BARTON: Open Payments
NPI 1508524240 · MONMOUTH JUNCTION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 15 payments from 9 companies in 2025. Trend: 2023 $322 · 2024 $327 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $79 |
| Ardelyx, Inc. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Exact Sciences Corporation | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Vifor Pharma, Inc. | 1 | $17 |
Products named: Ozempic, Kerendia, IBSRELA, Fabhalta, Cologuard Collection Kit, FUROSCIX, XIFAXAN, JYNARQUE.
Industry payments across NJ — which companies pay providers there.
